General information
  • Disease category Mental and Behavioural diseases (BASEC)
  • Recruitment status recruitment not started yet (BASEC/ICTRP)
  • Trial sites
    Bern, Other
    (BASEC)
  • Contact Prof Monika Müller, MD PhD monika_mueller@gmx.ch (BASEC)
  • Data Source(s) BASEC: Import from 17.04.2025 ICTRP: N/A
  • Last update 17.04.2025 13:50
HumRes66756 | SNCTP000006371 | BASEC2024-00727

Evaluation of a combination therapy with psychological short therapy and antidepressants for the treatment of depression in Zimbabwe.

  • Disease category Mental and Behavioural diseases (BASEC)
  • Recruitment status recruitment not started yet (BASEC/ICTRP)
  • Trial sites
    Bern, Other
    (BASEC)
  • Contact Prof Monika Müller, MD PhD monika_mueller@gmx.ch (BASEC)
  • Data Source(s) BASEC: Import from 17.04.2025 ICTRP: N/A
  • Last update 17.04.2025 13:50

Summary description of the study

Mental illnesses such as depression are increasing even in resource-poor countries. It is the most common mental illness in Africa. Although one in four patients in primary care suffers from depression, up to 90% of them remain untreated. This is partly due to the lack of specialists. The research project collaborates with the 'Friendship Bench.' This locally developed program in Zimbabwe aims to close this gap in care. To improve treatment outcomes for depression, we want to combine the psychological short intervention of the 'Friendship Bench' with antidepressants. These will be administered by trained health personnel without specialization in psychiatry. Our clinical study compares the psychological short intervention of the 'Friendship Bench' with the 'Friendship Bench' plus antidepressants and examines how many individuals still suffer from depression after four months. Our research follows international treatment guidelines. Zimbabwe is one of the WHO target countries under its special initiative to improve access to mental health care. Accordingly, our project is conducted in close collaboration with the Ministry of Health of Zimbabwe and the WHO. This ensures that our results achieve the necessary long-term impact.

(BASEC)

Intervention under investigation

We are investigating the 'Friendship Bench Plus Intervention.' This is a psychological short intervention provided by lay therapists consisting of six psychotherapy sessions plus antidepressants prescribed by nursing professionals.

(BASEC)

Disease under investigation

Moderate to severe depression.

(BASEC)

Criteria for participation in trial
We include adults (≥18 years) with moderate to severe depression who are seeking treatment at a health center in Harare and have not yet been treated for their depression. (BASEC)

Exclusion criteria
Individuals with severe physical comorbidities, with psychotic symptoms or high suicide risk, as well as pregnant women will be excluded. (BASEC)

Trial sites

Bern, Other

(BASEC)

Harare, Simbabwe

(BASEC)

not available

Sponsor

Universität Bern

(BASEC)

Contact

Contact Person Switzerland

Prof Monika Müller, MD PhD

+41 31 930 91 11

monika_mueller@gmx.ch

Universitätsklinik für Psychiatrie und Psychotherapie der UPD Bern (Gastdozentin, Korrespondenz bitte an Privatadresse Monika Müller, Stürlerstrasse 5, 3006 Bern)

(BASEC)

Scientific Information

not available

Name of the authorising ethics committee (for multicentre studies, only the lead committee)

Ethics Committee Bern

(BASEC)

Date of authorisation

19.03.2025

(BASEC)


ICTRP Trial ID
not available

Official title (approved by ethics committee)
Combining antidepressants with psychological therapy to improve depression outcome in Zimba-bwe - the Friendship Bench Plus trial (FB+Trial) (BASEC)

Academic title
not available

Public title
not available

Disease under investigation
not available

Intervention under investigation
not available

Type of trial
not available

Trial design
not available

Inclusion/Exclusion criteria
not available

not available

Primary and secondary end points
not available

not available

Registration date
not available

Incorporation of the first participant
not available

Secondary sponsors
not available

Additional contacts
not available

Secondary trial IDs
not available

Results-Individual Participant Data (IPD)
not available

Further information on the trial
not available

Results of the trial

Results summary

not available

Link to the results in the primary register

not available